1. Home
  2. FLGT vs IGR Comparison

FLGT vs IGR Comparison

Compare FLGT & IGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • IGR
  • Stock Information
  • Founded
  • FLGT 2011
  • IGR 2004
  • Country
  • FLGT United States
  • IGR United States
  • Employees
  • FLGT N/A
  • IGR N/A
  • Industry
  • FLGT Medical Specialities
  • IGR Finance Companies
  • Sector
  • FLGT Health Care
  • IGR Finance
  • Exchange
  • FLGT Nasdaq
  • IGR Nasdaq
  • Market Cap
  • FLGT 683.5M
  • IGR 691.7M
  • IPO Year
  • FLGT 2016
  • IGR N/A
  • Fundamental
  • Price
  • FLGT $17.40
  • IGR $5.19
  • Analyst Decision
  • FLGT Hold
  • IGR
  • Analyst Count
  • FLGT 1
  • IGR 0
  • Target Price
  • FLGT $22.00
  • IGR N/A
  • AVG Volume (30 Days)
  • FLGT 248.2K
  • IGR 747.7K
  • Earning Date
  • FLGT 02-26-2025
  • IGR 01-01-0001
  • Dividend Yield
  • FLGT N/A
  • IGR 13.93%
  • EPS Growth
  • FLGT N/A
  • IGR N/A
  • EPS
  • FLGT N/A
  • IGR N/A
  • Revenue
  • FLGT $277,761,000.00
  • IGR N/A
  • Revenue This Year
  • FLGT N/A
  • IGR N/A
  • Revenue Next Year
  • FLGT $16.00
  • IGR N/A
  • P/E Ratio
  • FLGT N/A
  • IGR N/A
  • Revenue Growth
  • FLGT N/A
  • IGR N/A
  • 52 Week Low
  • FLGT $16.56
  • IGR $3.88
  • 52 Week High
  • FLGT $26.74
  • IGR $5.70
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 40.35
  • IGR 52.88
  • Support Level
  • FLGT $16.76
  • IGR $4.76
  • Resistance Level
  • FLGT $17.83
  • IGR $5.29
  • Average True Range (ATR)
  • FLGT 0.65
  • IGR 0.11
  • MACD
  • FLGT -0.09
  • IGR 0.07
  • Stochastic Oscillator
  • FLGT 25.58
  • IGR 80.19

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About IGR CBRE Global Real Estate Income Fund of Beneficial Interest

CBRE Clarion Global Real Estate Income Fund is the United States based diversified, closed-end management investment company. Its objective is high current income and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities located mainly in the developed markets of North America, Europe, Australia, and Asia. Its portfolio of investments consists of different sectors such as diversified, retail, industrial, residential, hotels, healthcare, and other sectors.

Share on Social Networks: